Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Patent
1990-12-07
1994-03-08
Kepplinger, Esther L.
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
435 71, 435 721, 435 723, 435962, 436501, 436504, 436514, 436516, 436 63, 436 64, 436813, 436824, 2041828, C12Q 168, G01N 33574, G01N 33561
Patent
active
052926389
ABSTRACT:
A method and assay for determination of functionality of steroid receptors present in breast or other tumors. The method is useful for determination of cancer responsiveness to hormonal therapy by establishing a correlation between functioning estrogen receptors and those which are dysfunctional or nonfunctional. The assay is useful for determination whether the cancer, particularly the breast cancer, will respond to anti-estrogen hormonal therapy.
REFERENCES:
Klein-Hitpass, L., et al., Mol. Cell. Biol., vol. 9, No. 1, pp. 43-49 (Jan. 1989).
Murdoch, F. E., et al., Biochemistry, vol. 29, pp. 8377-8385 (Sep. 1990).
Peale, F. V., et al., Biochemistry, vol. 28, No. 22, pp. 8671-8675 (Oct. 31, 1989).
Hoehn, J. L., et al., Biological Abstracts, vol. 69, No. 3, The Abstract No. 18110, (Feb. 1980).
C. C. Benz, G. K. Scott, Abstract: Can. Gel-shift Assays Detect Hormone Resistant ER-Positive Breast Cancers?, Breast Cancer Res. Treat., 14:178 (1989), Editor W. L. McGuire, Kluwer Academic Publishers.
V. Kumar, P. Chambron, The Estrogen Receptor Binds Tightly to its Responsive Element as a Ligand-Induced Homodimer Cell, 55:145 (1988).
F. Keeman, UCSF Specialist Questions Therapy for Breast Cancer, San Francisco Examiner, A-16 Tuesday, Mar. 27, 1990.
Associated Press, Soybeans May Prevent Breast Cancer, A5, Marin Independent Journal, Tuesday, Mar. 27, 1990.
R. Knox, Odds of Breast Cancer Relapse May be Misstated, Scientist Says, Boston Globe, Mar. 26, 1990.
T. Friend, Other Promising Research, USA Today-Life, Mar. 27, 1990.
G. Scott, P. Kushner, J. L. Vigne, and C. Benz, J. Clin. Invest., Truncated Forms of DNA-binding Estrogen Receptors in Human Breast Cancer, Journal of Clinical Investigation, Inc., vol. 88, 700-706, (Aug. 1991).
Benz Christopher C.
Scott Gary K.
Dolezalova Hana
Kepplinger Esther L.
Scheiner Toni R.
The Regents of the University of California
LandOfFree
Method of determining functional estrogen receptors for prognosi does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of determining functional estrogen receptors for prognosi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of determining functional estrogen receptors for prognosi will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-152492